After ROSC, coma should not be the gatekeeper for the cath lab. The harder task is recognizing that the ECG, low output, and neurologic examination may reflect several overlapping injuries—and managing the time-critical problems in parallel.
Consider a 62-year-old man with witnessed ventricular fibrillation, successful defibrillation, and ROSC before emergency department arrival. He is intubated, hypotensive, cool, and poorly perfused. His post-ROSC ECG shows persistent anterior ST-segment elevation, while bedside echocardiography shows severe global left ventricular dysfunction.
Before sedation and resuscitation obscure the story, collateral history should establish baseline function, antecedent chest pain or dyspnea, medication exposure—especially beta-blockers—comorbidities, downtime, bystander CPR, and the patient’s known goals. If those facts are unavailable, preserve the uncertainty rather than filling it in.
A low ejection fraction is supportive, not diagnostic, of cardiogenic shock. The shock diagnosis rests on clinical and laboratory evidence of inadequate perfusion: hypotension, cool extremities, oliguria, altered mental status, rising lactate, or other end-organ injury in the appropriate context.
The ECG is an urgent action trigger, not the whole diagnosis
Persistent ST elevation after cardiac arrest strongly raises concern for acute coronary occlusion, but it does not exclude post-arrest myocardial dysfunction or another reversible cause. The immediate differential should remain active while the team prepares for coronary angiography.
| Possibility | Discriminating clues | Immediate implication |
|---|---|---|
| Acute coronary occlusion | Persistent ST elevation, VF as the initial rhythm, regional wall-motion abnormality, antecedent ischemic symptoms | Activate emergent coronary angiography and support perfusion |
| Post-arrest myocardial dysfunction | Global hypokinesis, low cardiac output, evolving lactate and urine output | Treat shock, reassess frequently; it may coexist with infarction |
| Pulmonary embolism with RV failure | RV dilation, septal flattening, venous congestion, compatible history | Pursue a PE pathway rather than assuming isolated LV failure |
| Tamponade, tension pneumothorax, or major blood loss | Pericardial fluid, absent lung sliding, poor venous return, trauma or bleeding clues | Correct the mechanical or volume problem immediately |
Point-of-care ultrasound refines the differential; it does not replace the ECG, serial examination, or definitive imaging. Global hypokinesis can represent transient post-arrest stunning, but acute LAD occlusion and stunning can occur together.
Go to the cath lab while stabilizing the patient
For a patient with a suspected cardiac cause of arrest and persistent ST-segment elevation, emergency coronary angiography should be performed regardless of coma. Waiting for awakening, a reassuring neurologic examination, or a peak troponin value should not delay reperfusion.
The neurologic and cardiac plans should run concurrently. Temperature control, arterial access, blood gas assessment, seizure surveillance, and critical care consultation can proceed while the interventional team addresses the likely culprit lesion. If shock and multivessel coronary disease are encountered, an initial culprit-lesion strategy is generally favored over routine immediate multivessel intervention.
Pressure first, flow next
In the emergency phase, a patient with marked hypotension and hypoperfusion needs restored perfusion pressure before a pure inotrope is used alone. A titratable vasopressor—often norepinephrine in cardiogenic shock practice—is reasonable, while recognizing that post-arrest evidence does not establish one universally superior vasopressor. The practical target is to avoid hypotension, with a minimum MAP of at least 65 mm Hg as a starting point.
Fluids should be selective. A small test bolus may be reasonable when ultrasound and history suggest hypovolemia or preload responsiveness, but repeated empiric liters can worsen pulmonary edema and ventricular loading in a patient with severe LV dysfunction.
Once blood pressure is supported but low output persists, an inotrope may be added. The choice is physiologic rather than memorized.
| Drug | Mechanism | Practical trade-offs |
|---|---|---|
| Dobutamine | Predominantly beta-1 stimulation with some beta-2 vasodilation | Short-acting and readily titratable; may increase heart rate, myocardial oxygen demand, and arrhythmia risk |
| Milrinone | PDE-3 inhibition, increasing intracellular cyclic AMP and producing inotropy plus vasodilation | Less dependent on beta-receptor stimulation; longer effect, renal clearance, and greater risk of hypotension |
In the randomized DOREMI trial of cardiogenic shock—which excluded patients presenting after out-of-hospital cardiac arrest—milrinone and dobutamine did not differ in the composite outcome or key secondary outcomes. These findings should not be overgeneralized to postarrest shock. Milrinone may be considered when a non-beta-mediated mechanism or pulmonary vasodilation is desirable, but neither chronic beta-blocker exposure nor pulmonary vascular disease is an automatic indication. Severe hypotension, renal dysfunction, tachyarrhythmia, and the need for rapid titration often push the decision toward dobutamine or continued vasopressor-supported therapy.
Temperature and gas exchange are part of hemodynamic care
Keep 100% oxygen until oxygenation can be measured reliably. Then titrate the fraction of inspired oxygen to avoid both hypoxemia and hyperoxemia; a reasonable target is an SpO₂ of 90% to 98% or a PaO₂ of 60 to 105 mm Hg. For a comatose mechanically ventilated patient, measure PaCO₂ with an arterial blood gas when needed and target normocapnia, generally 35 to 45 mm Hg.
For patients who remain unresponsive to verbal commands, use a deliberate, protocolized temperature-control strategy within 32°C to 37.5°C. Current guidance considers at least 36 hours of temperature control reasonable. The exact target should be selected by protocol and patient factors, but temperature management must not become a reason to postpone coronary reperfusion.
Day-one twitching is not a neurologic verdict
Myoclonus after ROSC deserves prompt EEG, not reflexive prognostication. Clinical appearance alone cannot reliably determine whether the movements represent electroclinical seizures, status epilepticus, or nonepileptic myoclonus. Treat documented seizures; do not use myoclonus alone to declare irreversible brain injury.
Neuroprognostication should be multimodal and delayed until confounding from sedatives, neuromuscular blockade, temperature, metabolic abnormalities, and organ failure has been addressed. A practical anchor is at least 72 hours after normothermia and sedative discontinuation; patients treated with hypothermic temperature control may require a later calendar time. Early family conversations should be transparent: the team can describe what is known, what remains uncertain, and when the next meaningful assessment is expected.
Common traps
- Coma means no PCI: false when persistent ST elevation or another unstable cardiac indication is present.
- EF 20% means permanent infarction: false; post-arrest myocardial dysfunction may improve, although recovery does not exclude infarction.
- Milrinone is automatically better with beta-blockade: too simplistic; consider blood pressure, renal function, rhythm, and titratability.
- TTM means 32°C to 36°C for exactly 24 hours: outdated shorthand that does not reflect current temperature-control guidance.
- Myoclonus equals poor outcome: unsafe without EEG characterization and multimodal, appropriately timed assessment.
Practical takeaways
- Persistent ST elevation after VF arrest and ROSC is a cath-lab problem even when the patient is comatose.
- Use ultrasound to identify competing or concurrent causes of shock, but do not let global hypokinesis delay reperfusion.
- Restore perfusion pressure first; add inotropy when low output persists despite adequate pressure.
- Dobutamine and milrinone are not proven outcome winners; choose based on physiology and adverse-effect profile.
- Target oxygenation and PaCO₂ deliberately, and use protocolized temperature control without delaying PCI.
- Obtain EEG for post-arrest myoclonus and postpone definitive neurologic impressions until confounders have cleared and multimodal data are available.